re: vcr beware- remember the dotcoms Cerebus, my one comment is in relation to - the investors were never into this stock - if you look at the recent shareholding you will find many investment insto's have holdings of a few percent each. I agree there are serious risks (but a lot fewer than previously) if you rate VCR by the 4P's (people, patents, potential and persitence) they are fairly priced. Even if the industry average of 1 in 5 patients in the trials has unfortunate outcomes. 101
VCR
ventracor limited
